Trials / Completed
CompletedNCT01073007
Stroke Treatment With Acute Reperfusion and Simvastatin
Multicentric, Randomized, Double-blind Clinical Trial to Evaluate the Efficacy of Simvastatin in the Acute Phase of Ischemic Stroke
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether simvastatin treatment started within the first 12 hours from stroke onset improves neurological and functional outcomes, evaluated at seventh day/discharge or at the third month. Also, to demonstrate that simvastatin is safe and not associated with higher rates of hemorrhagic transformation in patients who receive thrombolysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Simvastatin | Simvastatin 40 mgrs daily for three months. |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2010-02-22
- Last updated
- 2016-12-21
Locations
20 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01073007. Inclusion in this directory is not an endorsement.